| Ticker: RCGI | 1801 West End Avenue, Suite 1100 | |
| Exchange: NASDAQ-National Market | Nashville, Tennessee 37203 | |
| Industry: Service | (615) 327-1513 |
| Type of Shares: | Common Shares | Filing Date: | 12/11/95 | |
| U.S. Shares: | 3,900,000 | Offer Date: | 2/6/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $15.00 - $17.00 | |
| Primary Shares: | 3,900,000 | Offer Price: | $18.00 | |
| Secondary Shares: | 0 | Gross Spread: | $1.26 | |
| Offering Amount: | $62,400,000 | Selling: | $0.74 | |
| Expenses: | $1,000,000 | Reallowance: | $0.10 | |
| Shares Out After: | 8,731,000 |
| Manager | Tier | Phone |
| Equitable Securities Corporation | Lead Manager | (615) 780-9300 |
| Bear, Stearns & Co. Inc. | Co-manager | (212) 272-2000 |
| Morgan Keegan & Company, Incorporated | Co-manager | (901) 524-4100 |
| UBS Securities Inc. | Co-manager | (212) 230-4000 |
| Auditor: Ernst & Young | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/94 | 9/30/95 | 9/30/94 | 9/30/95 | ||
| Revenue: | $69.04 | $52.95 | $51.45 | Assets: | $37.87 |
| Net Income: | $11.36 | $8.08 | $9.03 | Liabilities: | $18.06 |
| EPS: | $0.72 | $0.53 | Equity: | $19.81 | |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is a national provider of dialysis and nephrology services for patients suffering from chronic kidney failure. The Company provides dialysis and ancillary services to approximately 2,700 patients through 41 outpatient dialysis centers in eight states, including two dialysis centers that are managed but not owned by the Company, one of which is the dialysis program at Vanderbilt University Medical Center. Renal Care Group also provides acute dialysis services through contractual relationships with 21 hospitals and physician practice management services to nine of the 30 nephrologists who are affiliated with the Company's outpatient dialysis centers. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to repay debt and other general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.